{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:22:02Z","timestamp":1791192122145,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1124\/dmd.107.019547","type":"journal-article","created":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T01:59:40Z","timestamp":1198202380000},"page":"500-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["A Human Immunodeficiency Virus Protease Inhibitor Is a Novel Functional Inhibitor of Human Pregnane X Receptor"],"prefix":"10.1016","volume":"36","author":[{"given":"Christine","family":"Healan-Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"Waring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale J.","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.G.","family":"Blomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rommel G.","family":"Tirona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.107.019547_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.qai.0000155203.89350.85","article-title":"Increased dose of lopinavir\/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected children","volume":"39","author":"Bergshoeff","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1124\/dmd.107.019547_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1124\/mol.105.022046","article-title":"Ketoconazole and miconazole are antagonists of the human glucocorticoid receptor: consequences on the expression and function of the constitutive androstane receptor and the pregnane X receptor","volume":"70","author":"Duret","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.019547_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-1003337","article-title":"Ketoconazole binds to the human androgen receptor","volume":"24","author":"Eil","year":"1992","journal-title":"Horm Metab Res"},{"key":"10.1124\/dmd.107.019547_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/jpet.105.098160","article-title":"Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor","volume":"317","author":"Faucette","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.107.019547_bib5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2165\/00003088-200241140-00004","article-title":"Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection","volume":"41","author":"Fichtenbaum","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.107.019547_bib6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/00498250601050412","article-title":"Attenuating pregnane X receptor (PXR) activation: a molecular modelling approach","volume":"37","author":"Gao","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.107.019547_bib7","first-page":"1329","article-title":"The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module","volume":"56","author":"Goodwin","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.019547_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0026-895X(24)12603-X","article-title":"Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor","volume":"60","author":"Goodwin","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.019547_bib9","doi-asserted-by":"crossref","first-page":"17882","DOI":"10.1074\/jbc.M601302200","article-title":"Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents","volume":"281","author":"Gu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.019547_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1124\/pr.55.4.2","article-title":"Induction of drug metabolism: the role of nuclear receptors","volume":"55","author":"Handschin","year":"2003","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.107.019547_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.clpt.6100027","article-title":"Lopinavir\/ritonavir reduces bupropion plasma concentrations in healthy subjects","volume":"81","author":"Hogeland","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.107.019547_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/dmd.30.7.795","article-title":"CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes","volume":"30","author":"Luo","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.019547_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/138920007779815986","article-title":"Transcriptional regulation and expression of CYP3A4 in hepatocytes","volume":"8","author":"Martinez-Jimenez","year":"2007","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.107.019547_bib14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1210\/me.2007-0025","article-title":"A common polymorphism in the bile acid receptor FXR is associated with decreased hepatic target gene expression","volume":"21","author":"Marzolini","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1124\/dmd.107.019547_bib15","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biocel.2006.08.017","article-title":"Pregnane X receptor: promiscuous regulator of detoxification pathways","volume":"39","author":"Matic","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/dmd.107.019547_bib16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ajog.2005.01.040","article-title":"Metabolites of progesterone and the pregnane X receptor: a novel pathway regulating uterine contractility in pregnancy?","volume":"192","author":"Mitchell","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/dmd.107.019547_bib17","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1074\/jbc.M110244200","article-title":"A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway","volume":"277","author":"Morimitsu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.019547_bib18","first-page":"50","article-title":"Evaluation of the toxicological relevance of CYP3A4 induction","volume":"6","author":"Plant","year":"2003","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1124\/dmd.107.019547_bib19","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbrc.2005.04.071","article-title":"Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I","volume":"331","author":"Sporstol","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.107.019547_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/03602530600786232","article-title":"PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity","volume":"38","author":"Stanley","year":"2006","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.107.019547_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/87912","article-title":"The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux","volume":"7","author":"Synold","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/dmd.107.019547_bib22","doi-asserted-by":"crossref","first-page":"43919","DOI":"10.1074\/jbc.M303136200","article-title":"Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR","volume":"278","author":"Tabb","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.019547_bib23","doi-asserted-by":"crossref","first-page":"32453","DOI":"10.1074\/jbc.M111245200","article-title":"Putative role of the orphan nuclear receptor SXR (steroid and xenobiotic receptor) in the mechanism of CYP3A4 inhibition by xenobiotics","volume":"277","author":"Takeshita","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.019547_bib24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/jps.20324","article-title":"Nuclear receptors and drug disposition gene regulation","volume":"94","author":"Tirona","year":"2005","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.107.019547_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nm815","article-title":"The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4","volume":"9","author":"Tirona","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/dmd.107.019547_bib26","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1124\/mol.105.021220","article-title":"A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes","volume":"69","author":"Ueda","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.019547_bib27","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/0091270007299930","article-title":"Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs","volume":"47","author":"Urquhart","year":"2007","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.107.019547_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd753","article-title":"PXR, CAR and drug metabolism","volume":"1","author":"Willson","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.107.019547_bib29","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/toxsci\/kfi094","article-title":"Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats","volume":"84","author":"Wong","year":"2005","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.107.019547_bib30","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.bmc.2006.12.026","article-title":"Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism","volume":"15","author":"Xue","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/dmd.107.019547_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0006-2952(97)00476-0","article-title":"Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-null mouse","volume":"55","author":"Zaher","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.019547_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/dkh029","article-title":"Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients","volume":"53","author":"Zeldin","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/dmd.107.019547_bib33","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1210\/me.2006-0291","article-title":"Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis","volume":"21","author":"Zhai","year":"2007","journal-title":"Mol Endocrinol"},{"key":"10.1124\/dmd.107.019547_bib34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00008571-200110000-00003","article-title":"The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants","volume":"11","author":"Zhang","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1124\/dmd.107.019547_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbrc.2005.12.203","article-title":"Preferential inducibility of CYP1A1 and CYP1A2 by TCDD: differential regulation in primary human hepatocytes versus transformed human cells","volume":"341","author":"Zhang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.107.019547_bib36","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI27793","article-title":"Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia","volume":"116","author":"Zhou","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.107.019547_bib37","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.106.029264","article-title":"The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor","volume":"71","author":"Zhou","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.019547_bib38","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI26283","article-title":"Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation","volume":"116","author":"Zhou","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.107.019547_bib39","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1074\/jbc.M511116200","article-title":"A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway","volume":"281","author":"Zhou","year":"2006","journal-title":"J Biol Chem"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624015952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624015952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.107.019547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:20:01Z","timestamp":1739895601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624015952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0090955624015952"],"URL":"https:\/\/doi.org\/10.1124\/dmd.107.019547","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Human Immunodeficiency Virus Protease Inhibitor Is a Novel Functional Inhibitor of Human Pregnane X Receptor","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.107.019547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}